Abstract
Backgrounds
Patients with cancer presented a lower probability to obtain seroconversion after a complete course of COVID-19 vaccination. However, little was known on the factors that predict poor seroconversion in this frail population.
Methods
We searched the PubMed, EMBASE, and China National Knowledge Infrastructure databases for all articles within a range of published years from 2019 to 2022 on the predictors of response to COVID-19 vaccine in patients with cancer (last search was updated on 2st March 2022). The odds ratio corresponding to the 95% confidence interval was used to assess the outcome. The statistical heterogeneity among studies was assessed with the Q-test and I2 statistics. The review was registered with PROSPERO (CRD42022315687) and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
Results
Twenty cohort studies met the inclusion criteria for this study, with 5,499 patients with cancer. We found that advanced age, male patients, and metastatic disease increased negative seropositivity to COVID-19 vaccine. Immunoglobulin heavy chain variable mutation status, high concentration of Ig G, Ig M, and Ig A were correlated with seropositivity. Relating to cancer treatment strategy, anti-CD20 therapy within recent 12 months and chemotherapy were negatively correlated with seroconversion. Meta-analysis found no significant difference associated with targeted treatment, immunotherapy, and endocrine treatment.
Conclusions
Our meta-analysis assessed the factors that predict poor seroconversion in order to plan better prevention strategies in this frail population. The results proposed that enhanced vaccination strategies would be beneficial for the special patients such as advanced male, or patients receiving active chemotherapy, and carefully prevention should be emphasised even after a complete course of vaccination.
【저자키워드】 Meta-analysis, COVID-19 vaccine, predictors, Cancer patients, Serologic response, 【초록키워드】 Treatment, review, vaccination, Mutation, Immunotherapy, Cancer, outcome, database, heterogeneity, anti-CD20 therapy, cohort study, Chemotherapy, China, Probability, Seroconversion, COVID-19 vaccination, male, Patient, Reporting, predictor, cancer treatment, patients, predict, Concentration, Endocrine, Odds ratio, Vaccination strategy, Patients with cancer, Infrastructure, Factor, no significant difference, 95% confidence interval, inclusion criteria, advanced age, item, Registered, article, metastatic disease, Complete, statistical, Course, Result, was used, reported, receiving, searched, correlated, Relating, 【제목키워드】 systematic review, Patient,